FDA drug class
Direct Thrombin Inhibitors list
Every FDA-approved prescription drug the FDA NDC directory tags with the Direct Thrombin Inhibitor [EPC] class, with brand names and DEA schedules.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
The FDA NDC directory lists 3 single-ingredient drugs in this class: argatroban, bivalirudin, dabigatran etexilate.
Run it in Rivvi
Map your top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Direct Thrombin Inhibitors (3)
| Drug | Brand names | Type | NDC listings | DEA schedule |
|---|---|---|---|---|
| Argatroban | None listed | Single ingredient | 18 | Not controlled |
| Bivalirudin | None listed | Single ingredient | 15 | Not controlled |
| Dabigatran etexilate | Pradaxa | Single ingredient | 51 | Not controlled |
FDA established pharmacologic class: Direct Thrombin Inhibitor [EPC].
Questions
What drugs are Direct Thrombin Inhibitors?
The FDA NDC directory lists 3 single-ingredient drugs in this class: argatroban, bivalirudin, dabigatran etexilate.
Where does this list come from?
From the established pharmacologic class (EPC) field FDA publishes for each listing in the NDC directory. A drug is listed when most of its prescription listings carry the class.